The head of Hong Kong’s new drug regulatory body has pledged to build a fully capable and globally trusted agency that will become a catalyst for medical innovation rather than merely acting as a “miniature version” of existing overseas models. Dr Li Zili...
Interesting to see Hong Kong aim for a globally trusted drug regulator rather than just copying overseas models. Curious how CMPR will differ from mainland China, Singapore and Japan's approaches. #AsiaNews
wrote a new blog entry:
